Comprehensive Stock Comparison
Compare Auna S.A. (AUNA) vs Ardent Health Partners, LLC (ARDT) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | AUNA | 14.5% revenue growth vs ARDT's 10.3% |
| Value | AUNA | Lower P/E (1.6x vs 7.4x) |
| Quality / Margins | AUNA | 4.3% net margin vs ARDT's 3.2% |
| Stability / Safety | AUNA | Beta 0.43 vs ARDT's 0.88 |
| Dividends | AUNA | 0.1% yield; ARDT pays no meaningful dividend |
| Momentum (1Y) | ARDT | -35.9% vs AUNA's -38.1% |
| Efficiency (ROA) | ARDT | 4.0% ROA vs AUNA's 2.5%, ROIC 9.7% vs 10.0% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Auna S.A. is a Latin American healthcare provider operating hospitals and clinics across Mexico, Peru, and Colombia. It generates revenue primarily through prepaid healthcare plans in Peru—which likely represent its largest segment—along with dental and vision plans in Mexico, with hospital services contributing additional income. The company's competitive advantage lies in its integrated healthcare network across multiple Latin American markets, creating economies of scale and cross-border operational expertise.
Ardent Health Partners operates a network of acute care hospitals and clinics providing comprehensive healthcare services across the United States. It generates revenue primarily from patient care services — including inpatient and outpatient treatments, surgeries, and rehabilitation — with the majority coming from government and private insurance reimbursements. The company benefits from its regional concentration in key markets, which creates operational efficiencies and strong local physician relationships that drive patient referrals.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
AUNA leads in 3 of 6 categories (Financial Metrics, Valuation Metrics). ARDT leads in 3 (Profitability & Efficiency, Total Returns).
Financial Metrics (TTM)
ARDT is the larger business by revenue, generating $6.3B annually — 1.5x AUNA's $4.2B. Profitability is closely matched — net margins range from 4.3% (AUNA) to 3.2% (ARDT). On growth, ARDT holds the edge at +8.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | AUNAAuna S.A. | ARDTArdent Health Par… |
|---|---|---|
| RevenueTrailing 12 months | $4.2B | $6.3B |
| EBITDAEarnings before interest/tax | $827M | $948M |
| Net IncomeAfter-tax profit | $183M | $205M |
| Free Cash FlowCash after capex | $500M | $155M |
| Gross MarginGross profit ÷ Revenue | +38.7% | +70.6% |
| Operating MarginEBIT ÷ Revenue | +14.6% | +12.6% |
| Net MarginNet income ÷ Revenue | +4.3% | +3.2% |
| FCF MarginFCF ÷ Revenue | +11.9% | +2.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.1% | +8.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -50.8% | -189.5% |
Valuation Metrics
At 5.9x trailing earnings, ARDT trades at a 46% valuation discount to AUNA's 11.0x P/E. On an enterprise value basis, AUNA's 4.4x EV/EBITDA is more attractive than ARDT's 5.6x.
| Metric | AUNAAuna S.A. | ARDTArdent Health Par… |
|---|---|---|
| Market CapShares × price | $161M | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $1.2B | $3.1B |
| Trailing P/EPrice ÷ TTM EPS | 10.99x | 5.94x |
| Forward P/EPrice ÷ next-FY EPS est. | 1.56x | 7.38x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.08x |
| EV / EBITDAEnterprise value multiple | 4.39x | 5.55x |
| Price / SalesMarket cap ÷ Revenue | 0.12x | 0.22x |
| Price / BookPrice ÷ Book value/share | 0.75x | 0.82x |
| Price / FCFMarket cap ÷ FCF | 0.93x | 10.51x |
Profitability & Efficiency
ARDT delivers a 12.6% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $10 for AUNA. ARDT carries lower financial leverage with a 1.50x debt-to-equity ratio, signaling a more conservative balance sheet compared to AUNA's 2.32x. On the Piotroski fundamental quality scale (0–9), ARDT scores 8/9 vs AUNA's 6/9, reflecting strong financial health.
| Metric | AUNAAuna S.A. | ARDTArdent Health Par… |
|---|---|---|
| ROE (TTM)Return on equity | +10.1% | +12.6% |
| ROA (TTM)Return on assets | +2.5% | +4.0% |
| ROICReturn on invested capital | +10.0% | +9.7% |
| ROCEReturn on capital employed | +12.7% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 |
| Debt / EquityFinancial leverage | 2.32x | 1.50x |
| Net DebtTotal debt minus cash | $3.5B | $1.7B |
| Cash & Equiv.Liquid assets | $236M | $557M |
| Total DebtShort + long-term debt | $3.8B | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | 2.08x | 7.08x |
Total Returns (with DRIP)
A $10,000 investment in ARDT five years ago would be worth $5,847 today (with dividends reinvested), compared to $5,563 for AUNA. Over the past 12 months, ARDT leads with a -35.9% total return vs AUNA's -38.1%. The 3-year compound annual growth rate (CAGR) favors ARDT at -16.4% vs AUNA's -17.8% — a key indicator of consistent wealth creation.
| Metric | AUNAAuna S.A. | ARDTArdent Health Par… |
|---|---|---|
| YTD ReturnYear-to-date | +12.2% | +8.7% |
| 1-Year ReturnPast 12 months | -38.1% | -35.9% |
| 3-Year ReturnCumulative with dividends | -44.4% | -41.5% |
| 5-Year ReturnCumulative with dividends | -44.4% | -41.5% |
| 10-Year ReturnCumulative with dividends | -44.4% | -41.5% |
| CAGR (3Y)Annualised 3-year return | -17.8% | -16.4% |
Risk & Volatility
AUNA is the less volatile stock with a 0.43 beta — it tends to amplify market swings less than ARDT's 0.88 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | AUNAAuna S.A. | ARDTArdent Health Par… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.43x | 0.88x |
| 52-Week HighHighest price in past year | $8.72 | $15.55 |
| 52-Week LowLowest price in past year | $4.46 | $8.07 |
| % of 52W HighCurrent price vs 52-week peak | +61.2% | +60.4% |
| RSI (14)Momentum oscillator 0–100 | 60.9 | 55.7 |
| Avg Volume (50D)Average daily shares traded | 347K | 341K |
Analyst Outlook
Wall Street rates AUNA as "Hold" and ARDT as "Buy". Consensus price targets imply 55.2% upside for ARDT (target: $15) vs 42.9% for AUNA (target: $8).
| Metric | AUNAAuna S.A. | ARDTArdent Health Par… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $7.63 | $14.57 |
| # AnalystsCovering analysts | 1 | 12 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | — |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $0.02 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Aug 24 | Feb 26 | Change |
|---|---|---|---|
| Auna S.A. (AUNA) | 100 | 55.29 | -44.7% |
| Ardent Health Partn… (ARDT) | 111.89 | 53.49 | -52.2% |
Ardent Health Partn… (ARDT) returned -42% over 5 years vs Auna S.A. (AUNA)'s -44%.
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2024 | Change |
|---|---|---|---|
| Auna S.A. (AUNA) | $719M | $4.4B | +512.3% |
| Ardent Health Partn… (ARDT) | $2.1B | $6.0B | +183.4% |
Ardent Health Partners, LLC's revenue grew from $2.1B (2016) to $6.0B (2024) — a 13.9% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2024 | Change |
|---|---|---|---|
| Auna S.A. (AUNA) | 3.1% | 2.5% | -17.7% |
| Ardent Health Partn… (ARDT) | 0.7% | 3.5% | +408.3% |
Ardent Health Partners, LLC's net margin went from 1% (2016) to 4% (2024).
Chart 4EPS Growth — 10 Years
| Stock | 2016 | 2024 | Change |
|---|---|---|---|
| Auna S.A. (AUNA) | 0.59 | 1.63 | +176.3% |
| Ardent Health Partn… (ARDT) | 0.1 | 1.58 | +1480.0% |
Ardent Health Partners, LLC's EPS grew from $0.10 (2016) to $1.58 (2024) — a 41% CAGR.
Chart 5Free Cash Flow — 5 Years
Auna S.A. generated $578M FCF in 2024 (+645% vs 2021). Ardent Health Partners, LLC generated $128M FCF in 2024 (+167% vs 2022).
AUNA vs ARDT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is AUNA or ARDT a better buy right now?
Ardent Health Partners, LLC (ARDT) offers the better valuation at 5.9x trailing P/E (7.4x forward), making it the more compelling value choice. Analysts rate Ardent Health Partners, LLC (ARDT) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AUNA or ARDT?
On trailing P/E, Ardent Health Partners, LLC (ARDT) is the cheapest at 5.9x versus Auna S.A. at 11.0x. On forward P/E, Auna S.A. is actually cheaper at 1.6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AUNA or ARDT?
Over the past 5 years, Ardent Health Partners, LLC (ARDT) delivered a total return of -41.5%, compared to -44.4% for Auna S.A. (AUNA). A $10,000 investment in ARDT five years ago would be worth approximately $6K today (assuming dividends reinvested). Over 10 years, the gap is even starker: ARDT returned -41.5% versus AUNA's -44.4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AUNA or ARDT?
By beta (market sensitivity over 5 years), Auna S.A. (AUNA) is the lower-risk stock at 0.43β versus Ardent Health Partners, LLC's 0.88β — meaning ARDT is approximately 104% more volatile than AUNA relative to the S&P 500. On balance sheet safety, Ardent Health Partners, LLC (ARDT) carries a lower debt/equity ratio of 150% versus 2% for Auna S.A. — giving it more financial flexibility in a downturn.
05Which has better profit margins — AUNA or ARDT?
Ardent Health Partners, LLC (ARDT) is the more profitable company, earning 3.5% net margin versus 2.5% for Auna S.A. — meaning it keeps 3.5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AUNA leads at 16.1% versus 6.8% for ARDT. At the gross margin level — before operating expenses — ARDT leads at 82.7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is AUNA or ARDT more undervalued right now?
On forward earnings alone, Auna S.A. (AUNA) trades at 1.6x forward P/E versus 7.4x for Ardent Health Partners, LLC — 5.8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARDT: 55.2% to $14.57.
07Which pays a better dividend — AUNA or ARDT?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is AUNA or ARDT better for a retirement portfolio?
For long-horizon retirement investors, Auna S.A. (AUNA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.43)). Both have compounded well over 10 years (AUNA: -44.4%, ARDT: -41.5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between AUNA and ARDT?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.